Madrid / Chatham / Oxford / Toronto / London / Edinburgh / /
Company
Transgenic Technologies / genOway / Bernstein / Cox / Reaume AG / Edinburgh 3 Reaume AG / /
Country
Canada / United Kingdom / Scotland / /
Facility
National Cancer Institute of Canada /Eli Lilly Robert L. Noble Prize / The Hospital / Mount Sinai Hospital / University of Cambridge / University of Oxford / Samuel Lunenfeld Research Institute / University of Toronto / Brock University / /
Hospital for Sick Children / International Society for Stem Cell Research / Brock University / Samuel Lunenfeld Research Institute / Federation of American Societies for Experimental Biology / University of Oxford / ISTT Prize committee / National Cancer Institute of Canada /Eli Lilly Robert L. Noble Prize / University of Cambridge / Royal Society of Canada / Society for Developmental Biology / US National Academy of Science / International Society of Developmental Biologists / University of Toronto / Mount Sinai Hospital / /
Person
Andras Nagy / Ralph L. Brinster / Gene Trap / Chapman V / Béla Rozsnyay / A. Francis Stewart / Charles Babinet / Kenneth J. McCreath / Allan Bradley / Brigid Hogan / Janet Rossant / John Gurdon / Richard Gardner / /
Position
investigator / President and Vice-President / Chief of Research / Deputy Scientific Director / Scientist / current President / Vice-President / the CEO / leader / artist / Professor / pioneering researcher / Assistant Professor / Associate Professor / /
The International Society for Transgenic Technologies (ISTT) is pleased to announce that Professor Allan Bradley, Director Emeritus of the Wellcome Trust Sanger Institute (WTSI), and leading the Mouse Genomics Team at WT